Revisiting Preaddiction.

Autor: Miller SC; From the Mental Health Service, VA Medical Center, Dayton/Middletown, OH (SCM); Departments of Psychiatry & Population and Public Health Sciences, Boonshoft School of Medicine, Wright State University, Dayton, OH (SCM); Division of Addiction Medicine, Boston Children's Hospital, Boston, MA (SL); Department of Pediatrics, Harvard Medical School, Boston, MA (SL); Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA (AJS); Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA (AJS); Program in Addiction Medicine, Yale School of Medicine, New Haven, CT (JMT); Division of Addiction Psychiatry, Department of Psychiatry and Behavioral Health, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY (RNR); Department of Medicine, Harvard Medical School, Boston, MA (SW); Program in Substance Use and Addiction Services, Massachusetts General Hospital, Boston, MA (SW); and Friends Research Institute, Baltimore, MD (FV)., Levy S, Saxon AJ, Tetrault JM, Rosenthal RN, Wakeman S, Vocci F

Publikováno v: Journal of addiction medicine [J Addict Med] 2024 Sep-Oct 01; Vol. 18 (5), pp. 486-487. Date of Electronic Publication: 2024 Aug 10.

Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy.

Autor: Rose JE; Rose Research Center, 7240 ACC Blvd., Raleigh, NC, 27617, USA. jed.rose@roseresearchcenter.com., Behm FM; Rose Research Center, 7240 ACC Blvd., Raleigh, NC, 27617, USA., Botts TL; Rose Research Center, 7240 ACC Blvd., Raleigh, NC, 27617, USA., Botts DR; Rose Research Center, 7240 ACC Blvd., Raleigh, NC, 27617, USA., Willette PN; Rose Research Center, 7240 ACC Blvd., Raleigh, NC, 27617, USA., Vocci F; Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore, MD, 21201, USA., McCarty J; Nicotine BRST LLC, 8250 SW 27th Avenue, Ocala, FL, 34476, USA.

Publikováno v: Psychopharmacology [Psychopharmacology (Berl)] 2022 Sep; Vol. 239 (9), pp. 2853-2862. Date of Electronic Publication: 2022 Jun 30.

Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings.

Autor: Hooker, Stephanie A.¹ (AUTHOR) stephanie.a.hooker@healthpartners.com, Starkey, Colleen¹ (AUTHOR), Bart, Gavin² (AUTHOR), Rossom, Rebecca C.¹ (AUTHOR), Kane, Sheryl¹ (AUTHOR), Olson, Anthony W.³ (AUTHOR)

Publikováno v: BMC Primary Care. 10/11/2024, Vol. 25 Issue 1, p1-10. 10p.

A cholecystokinin B receptor antagonist and cocaine interaction, phase I study.

Autor: Elkashef A; Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Brašić JR; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Cantelina LR Jr; Division of Clinical Pharmacology and Medical Toxicology, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Kahn R; Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Chiang N; Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Ye W; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Zhou Y; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Mojsiak J; Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA., Warren KR; Department of Psychology, Morgan State University, Baltimore, MD, USA., Crabb A; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Hilton J; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Wong DF; Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.; Department of Psychiatry and Behavioral Sciences, Baltimore, MD, USA.; Department of Neurology, Baltimore, MD, USA.; Soloman H Snyder Department of Neurosciences, Baltimore, MD, USA.; Department of Environmental Health and Engineering, Bloomberg School of Public Health, Baltimore, MD, USA., Vocci F; Medications Development Division, The National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.; Friends Research Institute, Baltimore, MD, USA.

Publikováno v: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2019 Jan; Vol. 25 (1), pp. 136-146. Date of Electronic Publication: 2018 Jun 20.

The Effectiveness of Mindfulness in the Treatment of Methamphetamine Addiction Symptoms: Does Neuroplasticity Play a Role?

Autor: Chmiel, James¹ (AUTHOR) jameschmiel1@gmail.com, Malinowska, Agnieszka² (AUTHOR), Rybakowski, Filip³ (AUTHOR), Leszek, Jerzy⁴ (AUTHOR)

Publikováno v: Brain Sciences (2076-3425). Apr2024, Vol. 14 Issue 4, p320. 28p.